Pope Leo XIV returned to the Vatican on Sunday to lead the Angelus prayer . This public appearance follows a Tuesday surgery at Rome's Gemelli hospital to remove a malignant lung tumor.
The 90-minute removal of adenocarcinoma
Pope Leo XIV, the 71-year-old leader of the Catholic Church, underwent a 90-minute operation on Tuesday to remove a malignant lesion from his right lung. According to the report, the tumor was identified as adenocarcinoma, which is the most common variety of lung cancer. the procedure took place at Rome's Gemelli university hospital, a facility frequently used by pontiffs for medical crises.
Dr. Stefano Margaritora, the papal physician, has indicated that clinical signs suggest a favorable prognosis for the pontiff. Margaritora told Vatican News that Pope Leo XIV has dedicated his full effort to his recovery and is expected to return to full health. This event marks the first major medical emergency of the pontiff's 17-month tenure.
A return to St. Peter's Square and the Angelus
Following his discharge from Gemelli hospital on Saturday, Pope Leo XIV appeared before thousands of people in St . Peter's Square on Sunday. The first American-born pope delivered the Angelus prayer from the Apostolic Palace balcony, marking his first official duty since the surgery. As the report noted, the pontiff walked through the square with minimal assistance, signaling a rapid physical recovery that drew cheers of "Viva il papa!" from the crowd.
During the service, Pope Leo XIV reflected on the biblical teaching to "Give therefore to the emperor the things that are the emperor's, and to God the things that are God's," urging his followers to live with integrity. The emotional weight of the return was echoed by pilgrims like Claire Holland of Jacksonville, Florida, who told The Associated Press that she felt blessed to witness the strength of the determined leader.
A November itinerary spanning Uruguay, Argentina, and Peru
Despite the recent health crisis, Pope Leo XIV is maintaining a rigorous travel schedule from November 6 through November 17. This journey will take the pontiff to Uruguay, Argentina, and Peru, involving a demanding series of 12 flights and multiple helicopter trips to high-altitude regions. Such a schedule is physically taxing for any patient recovering from thoracic surgery, yet the pontiff intends to proceed with the trip.
This commitment reflects the global nature of his 17-month pontificate and his desire to remain active in pastoral care for the world's 1.4 billion Catholic believers . By pushing forward with the South American tour, Pope Leo XIV is signaling that his capacity to lead the global church remains intact despite the dignosis.
Breaking the Vatican's tradition of health secrecy
The level of detail provided regarding the health of Pope Leo XIV represents a significant shift in Vatican communications. Historically, the Holy See has maintained strict confidentiality regarding the medical status of the papacy, often keeping a "tight lid" on the specifics of a pope's illness until it became impossible to hide.
By disclosing the specific nature of the adenocarcinoma and the details of the Gemelli hospital stay, the Vatican is aligning itself with a more modern , transparent approach to leadership. this openness is seen as part of a broader mission to embrace pastoral care and transparency, moving away from the opacity that characterized the papacy in the 20th century.
Whether histology results will mandate chemotherapy
While the initial surgery was successful, the full scope of the treatment for Pope Leo XIV remains undetermined. Medical teams are currently conducting histology and molecular analysis of the tumor and sampled lymph nodes to determine the exact extent of the disease. This data is critical for deciding the next phase of the pontff's medical care.
It remains unclear if the 71-year-old pope will require chemotherapy, immunotherapy, or targeted oral medications to prevent a recurrence of the cancer. While the prognosis is currently favorable, the final medical plan depends on these pending laboratory results, which have not yet been released to the public.
Comments 0